200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 129689-30-1

129689-30-1

129689-30-1 | Acetamide, 2-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethoxy]phenoxy]-N-(2-methoxyethyl)-

CAS No: 129689-30-1 Catalog No: AG000TLX MDL No:

Product Description

Catalog Number:
AG000TLX
Chemical Name:
Acetamide, 2-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethoxy]phenoxy]-N-(2-methoxyethyl)-
CAS Number:
129689-30-1
Molecular Formula:
C22H30N2O6
Molecular Weight:
418.4834
IUPAC Name:
2-[4-[2-[[(2S)-2-hydroxy-3-phenoxypropyl]amino]ethoxy]phenoxy]-N-(2-methoxyethyl)acetamide
InChI:
InChI=1S/C22H30N2O6/c1-27-13-12-24-22(26)17-30-21-9-7-20(8-10-21)28-14-11-23-15-18(25)16-29-19-5-3-2-4-6-19/h2-10,18,23,25H,11-17H2,1H3,(H,24,26)/t18-/m0/s1
InChI Key:
RVMBDLSFFNKKLG-SFHVURJKSA-N
SMILES:
COCCNC(=O)COc1ccc(cc1)OCCNC[C@@H](COc1ccccc1)O
UNII:
EF5S87KTK2

Properties

Complexity:
439  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
418.21g/mol
Formal Charge:
0
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
418.49g/mol
Monoisotopic Mass:
418.21g/mol
Rotatable Bond Count:
15  
Topological Polar Surface Area:
98.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.7  

Literature

Title Journal
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20111201
Relaxation of human detrusor muscle by selective beta-2 and beta-3 agonists and endogenous catecholamines. Urology 20070401
Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response. Journal of molecular and cellular cardiology 20060401
Activation of beta3 adrenergic receptor decreases DNA synthesis in human skin fibroblasts via cyclic GMP/nitric oxide pathway. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20050101
Functional and molecular characterization of beta-adrenoceptors in the internal anal sphincter. The Journal of pharmacology and experimental therapeutics 20030501
Inhibitory effect of beta3-adrenoceptor agonist in lower esophageal sphincter smooth muscle: in vitro studies. The Journal of pharmacology and experimental therapeutics 20030101
Gastroprotective effect of beta3 adrenoreceptor agonists ZD 7114 and CGP 12177A in rats. Pharmacological research 20021001
Effect of postnatal age and a beta(3)-adrenergic agonist (Zeneca D7114) administration on uncoupling protein-1 abundance in the lamb. Experimental physiology 20010101
Adrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via beta3- and alpha1-adrenergic receptors. The Biochemical journal 19970201

Related Products

© 2019 Angene International Limited. All rights Reserved.